RBC Count vs Haematocrit: What Each Tells You on Cycle

RBC count and haematocrit are both reported on every complete blood count (CBC), both rise with anabolic steroid use, and both are used to monitor polycythemia. Despite this overlap, they measure fundamentally different things and behave differently under conditions common to enhanced athletes, most importantly dehydration and iron deficiency.

RBC count is the absolute number of red blood cells per litre of blood (expressed as x10^12/L). It is a direct count of individual cells regardless of their size or haemoglobin content. A high RBC count means there are more cells in circulation.

Haematocrit is the fraction of total blood volume occupied by red blood cells, expressed as a percentage. It is a volumetric measurement: it depends not just on how many cells are present, but on how big each cell is and how much fluid (plasma) surrounds them.

The divergence problem on cycle: On AAS, RBC count and haematocrit usually move together. But two common situations cause them to diverge: dehydration (which concentrates red cells in less plasma, raising haematocrit without changing RBC count) and iron deficiency from accelerated erythropoiesis (which produces smaller red cells, keeping haematocrit proportionally lower while RBC count may still be elevated). Recognising these divergent patterns prevents unnecessary phlebotomy for pseudopolycythemia and identifies the more dangerous pattern of true erythrocytosis.

What each measures:

• RBC count: Absolute number of red blood cells. A direct cellular count. Does not reflect cell size, haemoglobin content, or plasma volume.
• Haematocrit: Proportion of blood that is red cells. A volumetric measurement. Sensitive to both the number of cells (RBC count) and the size of each cell (MCV) and is diluted or concentrated by changes in plasma volume.

The mathematical relationship:

• Haematocrit is approximately equal to: RBC count x MCV / 10
• This means haematocrit is jointly determined by how many cells there are (RBC count) and how big those cells are (MCV)
• When MCV is stable, RBC count and haematocrit rise in parallel
• When MCV falls (iron deficiency producing smaller cells), haematocrit rises less than expected for a given RBC count

Susceptibility to dehydration:

• Haematocrit: Highly sensitive to dehydration. Plasma volume is the denominator in the haematocrit fraction. When plasma contracts from inadequate hydration, haematocrit rises by 2-5 percentage points without any change in the actual number of red blood cells. This is pseudopolycythemia.
• RBC count: Essentially unchanged by acute dehydration. The number of cells does not change, only the plasma volume around them. A haematocrit of 56% with a normal or unchanged RBC count is a strong signal of dehydration, not true polycythemia.

AAS-driven pattern versus dehydration pattern:

• True AAS-driven erythrocytosis: Both RBC count and haematocrit rise together. The MCHC may fall as production outpaces haemoglobin synthesis. Haemoglobin also rises in proportion.
• Dehydration (pseudopolycythemia): Haematocrit rises but RBC count stays the same. Haemoglobin rises in proportion to haematocrit (the ratio stays approximately 3:1). Resolves completely with rehydration.
• Iron depletion pattern: RBC count may be elevated or stable while haematocrit does not rise as much as expected. MCV drops. New cells are smaller, so even a high cell count produces less haematocrit per cell.

Clinical thresholds on TRT:

• Haematocrit: Most guideline-referenced threshold. The Endocrine Society recommends intervention above 54%.
• RBC count: No standardised intervention threshold for TRT in clinical guidelines. Concerning values are typically above 6.0-6.5 x10^12/L, but clinical decisions are based on haematocrit.
• The combination: When haematocrit crosses a threshold, checking RBC count alongside it clarifies whether the elevation is dehydration (normal RBC), true polycythemia (elevated RBC), or iron-depleted erythrocytosis (elevated RBC with falling MCV).

Use haematocrit for clinical decision-making on TRT:

• Haematocrit is the marker cited in TRT and AAS monitoring guidelines (Endocrine Society, AUA) for intervention decisions
• The 54% threshold for phlebotomy or dose reduction is the established clinical standard
• Track haematocrit as your primary polycythemia screening marker

Use RBC count to interpret haematocrit:

• When haematocrit is borderline or unexpectedly elevated, check RBC count to determine the mechanism
• A stable RBC count with a rising haematocrit suggests dehydration or increasing cell size (MCV rise from B12 deficiency)
• A rising RBC count with a stable or lower-than-expected haematocrit suggests iron depletion producing smaller cells

Use both together for on-cycle monitoring:

• Both are included in every CBC at no additional cost
• The pattern of their divergence is diagnostic: consistent with dehydration, iron deficiency, or genuine compound-driven erythropoiesis
• Check both at each monitoring draw and note which has changed more

Best screening tool:

• For the single most actionable screening number in a TRT patient, haematocrit is the better choice because it directly determines clinical intervention thresholds
• For understanding the mechanism behind an elevated haematocrit, RBC count alongside MCV and haemoglobin provides the full picture